SCHEMBL1762909

SCHEMBL1762909

CNCc1cc(-c2ccccc2)n(S(=O)(=O)c2ccccc2C#N)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
POLB P06746 1/20 0.38
KLK7 P49862 1/20 0.37
KDM4E B2RXH2 3/20 0.36
HPGD P15428 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GBA1 P04062 1/20 0.36
KDM2B Q8NHM5 1/20 0.36
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HDAC1 Q13547 1/20 0.35
NR3C1 P04150 1/20 0.35
SLC22A12 Q96S37 2/20 0.34
BRD1 O95696 1/20 0.34
BRPF1 P55201 1/20 0.34
IMPDH2 P12268 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1156591 0.99 PKM (0.38) PKMALDH1A1HTTPOLBKLK7
SCHEMBL1157223 0.88 BRAF (0.44) PKMALDH1A1HTTPOLBKLK7
SCHEMBL31019962 0.85 HTR2A (0.38) PKMALDH1A1HTTPOLBKLK7
SCHEMBL1580763 0.84 HTR2A (0.38) PKMALDH1A1HTTPOLBKLK7
SCHEMBL1580989 0.84 RAPGEF4 (0.42) HTTPOLBKLK7KDM4EGAA
Hydrochloric Acid SCHEMBL1157228 0.84 HTR2A (0.37) PKMALDH1A1HTTPOLBKLK7
Hydrochloric Acid SCHEMBL1156461 0.83 RAPGEF4 (0.41) HTTPOLBKLK7KDM4EGAA
SCHEMBL1580382 0.81 TUBB4A (0.38) KDM4EHPGDL3MBTL1
SCHEMBL1762825 0.81 SLC22A12 (0.36) ALDH1A1KDM4EHPGDL3MBTL1GAA
SCHEMBL1580474 0.81 LOXL2 (0.42) ALDH1A1GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9186411-B2 Pharmaceutical composition TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-11-17 US disclosed
US-20130261156-A1 PHARMACEUTICAL COMPOSITION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-10-03 US disclosed
EP-2564833-A1 Photostabilized pharmaceutical composition Takeda Pharmaceutical Company Limited (JP) 2013-03-06 EP disclosed
US-20110124687-A1 PHARMACEUTICAL COMPOSITION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124687-A1 PHARMACEUTICAL COMPOSITION CYP2C19, MLST8, CYP3A43 PKM 656/4885ALDH1A1 1146/4885HTT 1142/4885
US-20130261156-A1 PHARMACEUTICAL COMPOSITION CYP2C19, MLST8, CYP3A43 PKM 656/4885ALDH1A1 1146/4885HTT 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.